Induction therapy for active lupus nephritis: mycophenolate mofetil is superior to cyclophosphamide

Nat Clin Pract Rheumatol. 2006 Jul;2(7):354-5. doi: 10.1038/ncprheum0217.

Authors

Jennifer R Elliott¹, Susan Manzi

Affiliation

¹ Lupus Center of Excellence,University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.

PMID: 16932717
DOI: 10.1038/ncprheum0217

No abstract available

Publication types

Multicenter Study
Randomized Controlled Trial

MeSH terms

Adult
Cyclophosphamide / therapeutic use*
Female
Follow-Up Studies
Humans
Immunosuppressive Agents / therapeutic use*
Lupus Nephritis / drug therapy*
Male
Mycophenolic Acid / analogs & derivatives*
Mycophenolic Acid / therapeutic use
Prodrugs
Prospective Studies
Remission Induction
Severity of Illness Index
Treatment Outcome

Substances

Immunosuppressive Agents
Prodrugs
Cyclophosphamide
Mycophenolic Acid